BPOM Authorizes Phase 3 Clinical Trial for M72 TB Vaccine in Indonesia
The Food and Drug Monitoring Agency (BPOM) has approved phase 3 clinical trials for the M72 tuberculosis (TB) vaccine, aiming to assess its efficacy amid the country's high TB burden.
